A/S Novo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for A/S Novo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in ALDER BIOPHARMACEUTICALS INC ($ALDR) and 10% Owner in NEVRO CORP ($NVRO) and 10% Owner in ZS Pharma, Inc. ($ZSPH) and 10% Owner in Otonomy, Inc. ($OTIC) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA).
Latest Insider Trading Transactions of A/S Novo
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, ALDR, BMTI, FLXN, INGN, OPHT, NVRO, OTIC, ZSPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 18 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Buy | P | 17.00 | 500,000 | 8,500,000 | 2,283,131 | 1.8 M to 2.3 M (+28.04 %) |
Nov 17 2014 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | S | 40.20 | 995,000 | 39,999,000 | 5,901,819 | 6.9 M to 5.9 M (-14.43 %) |
Nov 13 2014 | NVRO | NEVRO CORP | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,979,841 | 0 | 0 | |
Nov 13 2014 | NVRO | NEVRO CORP | Novo A/S | 10% Owner | Buy | P | 18.00 | 215,000 | 3,870,000 | 2,194,841 | 2 M to 2.2 M (+10.86 %) |
Nov 13 2014 | NVRO | NEVRO CORP | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,979,841 | 0 | 1,979,841 | 0 to 2 M |
Nov 05 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Sell | S | 21.50 | 2,000,000 | 43,000,000 | 3,549,320 | 5.5 M to 3.5 M (-36.04 %) |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 11,488 | 3,446 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 52,018 | 15,605 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 2,727 | 818 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 5,570 | 1,671 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 12,681 | 3,804 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 19,022 | 5,707 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | X | 0.30 | 26,365 | 7,910 | 0 | |
Oct 17 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Buy | X | 38,961.30 | 129,871 | 5,059,942,992 | 5,549,320 | 5.4 M to 5.5 M (+2.40 %) |
Aug 21 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Buy | P | 15.50 | 15,690 | 243,135 | 2,175,025 | 2.2 M to 2.2 M (+0.73 %) |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 348,041 | 0 | 0 | |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,131,436 | 0 | 0 | |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 439,724 | 0 | 0 | |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Option Exercise | X | 0.00 | 31,854 | 0 | 0 | |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Option Exercise | X | 0.00 | 36,405 | 0 | 0 | |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Buy | P | 16.00 | 171,875 | 2,750,000 | 2,159,335 | 2 M to 2.2 M (+8.65 %) |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,919,201 | 0 | 1,987,460 | 68.3 K to 2 M (+2,811.65 %) |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Buy | X | 0.00 | 31,854 | 0 | 68,259 | 36.4 K to 68.3 K (+87.50 %) |
Aug 19 2014 | OTIC | Otonomy, Inc. | Novo A/S | 10% Owner | Buy | X | 0.00 | 36,405 | 0 | 36,405 | 0 to 36.4 K |
Jun 24 2014 | ZSPH | ZS Pharma, Inc. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 506,730 | 0 | 0 | |
Jun 24 2014 | ZSPH | ZS Pharma, Inc. | Novo A/S | 10% Owner | Buy | P | 18.00 | 275,000 | 4,950,000 | 781,730 | 506.7 K to 781.7 K (+54.27 %) |
Jun 24 2014 | ZSPH | ZS Pharma, Inc. | Novo A/S | 10% Owner | Buy | C | 0.00 | 506,730 | 0 | 506,730 | 0 to 506.7 K |
May 14 2014 | ALDR | ALDER BIOPHARMACEU ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 2,651,183 | 0 | 0 | |
May 14 2014 | ALDR | ALDER BIOPHARMACEU ... | Novo A/S | 10% Owner | Buy | P | 10.00 | 550,000 | 5,500,000 | 3,201,183 | 2.7 M to 3.2 M (+20.75 %) |
May 14 2014 | ALDR | ALDER BIOPHARMACEU ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 2,651,183 | 0 | 2,651,183 | 0 to 2.7 M |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 2,376,947 | 0 | 0 | |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,260,504 | 0 | 0 | |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 506,338 | 0 | 0 | |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 486,573 | 0 | 0 | |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,137 | 0 | 0 | |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 21,253 | 0 | 0 | |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Sell | S | 14.88 | 617,000 | 9,180,960 | 5,419,449 | 6 M to 5.4 M (-10.22 %) |
Feb 24 2014 | INGN | Inogen Inc | Novo A/S | 10% Owner | Buy | C | 0.00 | 5,948,056 | 0 | 6,036,449 | 88.4 K to 6 M (+6,729.10 %) |
Feb 20 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 8,868,393 | 0 | 0 | |
Feb 20 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Buy | P | 13.00 | 692,308 | 9,000,004 | 1,783,131 | 1.1 M to 1.8 M (+63.47 %) |
Feb 20 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,090,823 | 0 | 1,090,823 | 0 to 1.1 M |
Mar 26 2014 | AKBA | Akebia Therapeutic ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 714,285 | 0 | 0 | |
Mar 26 2014 | AKBA | Akebia Therapeutic ... | Novo A/S | 10% Owner | Buy | P | 17.00 | 182,590 | 3,104,030 | 1,516,387 | 1.3 M to 1.5 M (+13.69 %) |
Mar 26 2014 | AKBA | Akebia Therapeutic ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,333,797 | 0 | 1,333,797 | 0 to 1.3 M |
Oct 02 2013 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 15,438,009 | 0 | 0 | |
Oct 02 2013 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 5,208,334 | 0 | 0 | |
Oct 02 2013 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 14,374,443 | 0 | 0 | |
Oct 02 2013 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Buy | P | 22.00 | 455,000 | 10,010,000 | 6,896,819 | 6.4 M to 6.9 M (+7.06 %) |
Oct 02 2013 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Buy | C | 0.00 | 6,441,819 | 0 | 6,441,819 | 0 to 6.4 M |
Mar 06 2013 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Sell | D | 0.00 | 4,720,065 | 0 | 0 | 4.7 M to 0 (-100.00 %) |
Page: 1